EXPRESSION CASSETTE OF INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN AND AAV-BASED GENE DELIVERY SYSTEM

The present invention relates to a nucleic acid molecule encoding an interleukin 1 receptor antagonist protein, a transgenic expression cassette comprising the nucleic acid molecule, a gene delivery system comprising the transgenic expression cassette and use thereof. The transgenic expression cassette and the gene delivery system of the present invention can be used to treat various diseases that can be improved by blocking the IL-1 signaling pathway, including malignant tumors and inflammatory diseases, such as arthritis, particularly osteoarthritis..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 07. Sept. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

XIAO XIAO [VerfasserIn]
ZHOU KAIYI [VerfasserIn]
ZHENG JING [VerfasserIn]
ZHENG HAO [VerfasserIn]
JIANG WEI [VerfasserIn]
DU ZENGMIN [VerfasserIn]
ZHAO YANG [VerfasserIn]
CHEN CHEN [VerfasserIn]
WANG HUI [VerfasserIn]
WANG TIANYI [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
bio
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-09-07, Last update posted on www.tib.eu: 2023-10-19, Last updated: 2023-10-27

Patentnummer:

WO2023165477

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA018149650